Hyloris Pharmaceuticals SA HYLB.TU
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Hyloris Pharmaceuticals SA Stock Halal?
Shariah Compliance Analysis of HYLB.TU Stock
United Kingdom Health Care Micro Cap No. As of September 2026, Hyloris Pharmaceuticals SA (HYLB.TU) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Hyloris Pharmaceuticals SA does not pass Musaffa's business and financial screening criteria.
Hyloris Pharmaceuticals SA engages in the provision of development and reformulating of pharmaceutical products. The firm focus is on re-engineering cardiovascular products with a wide range of therapeutic indications and dosage forms. The company has two partnered commercial-stage products, Sotalol IV for the treatment of atrial fibrillation, and Maxigesic IV, dual mode-of-action non-opioid analgesic for the treatment of post-operative pain. Additionally, it develops the strategy of reformulating and repurposing already-approved pharmaceuticals primarily utilize the 505(b)(2) regulatory pathway in the U.S. and similar pathways in other countries, which are specifically designed for pharmaceutical agents for the safety and efficacy. The company also creates new and different solutions for the approved pharmaceuticals along with the technological requirements.
HYLB.TU Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Hyloris Pharmaceuticals SA is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Hyloris Pharmaceuticals SA (HYLB.TU) Chart
Financial Metrics & Statements of Hyloris Pharmaceuticals SA (HYLB.TU)
FAQ's for Hyloris Pharmaceuticals SA (HYLB.TU)
- As of September 2026, Hyloris Pharmaceuticals SA HYLB.TU is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Hyloris Pharmaceuticals SA using these criteria to determine its compliance status.
- Muslim investors may consider investing in Hyloris Pharmaceuticals SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Hyloris Pharmaceuticals SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Hyloris Pharmaceuticals SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Hyloris Pharmaceuticals SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Hyloris Pharmaceuticals SA (HYLB.TU)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
